Rocket One (RKTO) Preferred Shares (2017 - 2018)
Rocket One's (RKTO) quarterly Preferred Shares came in at $3.1 million in Q4 2018, up 1793241.04% year-over-year from N/an in Q4 2017, and up 1793241.04% quarter-over-quarter from $173.0 in Q4 2017.
Analysis
Rocket One (RKTO) Preferred Shares (2017 - 2018) Analysis & Trends
Rocket One has disclosed Preferred Shares across 2 years of filings, most recently posting $3.1 million for Q4 2018.
- In Q4 2018, Preferred Shares rose 1793241.04% year-over-year to $3.1 million; the TTM figure through Dec 2018 stood at $3.1 million (up 1793241.04% YoY), while the FY2018 annual figure was $3.1 million, up 1793241.04% from the prior year.
- Preferred Shares came in at $3.1 million for Q4 2018 at Rocket One, up from $173.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $3.1 million in Q4 2018 to a low of $173.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | - |